Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes
Journal of Infection and Public Health · 2025
DOI: 10.1016/j.jiph.2025.102873 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Othman AlOmeir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, COVID-19 Drug Treatment. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shaqra University, Northern Border University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. Electronic address: aalhowail@qu.edu.sa.
- Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. Electronic address: s.rabbani@qu.edu.sa.
- Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Diriyah, Riyadh 13713, Saudi Arabia; Research Center, Deanship of Scientific Research and Post-Graduate Studies, AlMaarefa University, Diriyah,…
- Department of Emergency Medical Services, College of Applied Sciences, AlMaarefa University, Diriyah, Riyadh 13713, Saudi Arabia. Electronic address: grafi@mcst.edu.sa.
- Center For Health Research, Northern Border University, Arar 73213, Saudi Arabia. Electronic address: abeda.mohammed@nbu.edu.sa.
Förderung
- Shaqra University
- Northern Border University
Zitieren
APA
AlOmeir, O., Alhowail, A. H., Rabbani, S. I., Asdaq, S. M. B., Gilkaramenthi, R., Khan, A., Imran, M., & Dzinamarira, T. (2025). Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102873
Vancouver
AlOmeir O, Alhowail AH, Rabbani SI, Asdaq SMB, Gilkaramenthi R, Khan A, et al. Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102873
BibTeX
@article{AlOmeir2025,
author = {AlOmeir, Othman and Alhowail, Ahmad H and Rabbani, Syed Imam and Asdaq, Syed Mohammed Basheeruddin and Gilkaramenthi, Rafiulla and Khan, Abida and Imran, Mohd and Dzinamarira, Tafadzwa},
title = {Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes},
journal = {Journal of Infection and Public Health},
year = {2025},
doi = {10.1016/j.jiph.2025.102873}
}
EUVIMED